Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies. - Wikidata - wikimedia - TriplyDB

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

http://www.wikidata.org/entity/Q33401165

about

Targeted Radionuclide Therapy of Human Tumors Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer Use of the uteroglobin platform for the expression of a bivalent antibody against oncofetal fibronectin in Escherichia coli.Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.Therapeutic vaccination targeting the tumour vasculature.Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology.8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland.Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of (131)I-L19SIP in a prostate cancer patient.De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.Aligning physics and physiology: Engineering antibodies for radionuclide delivery.Emerging classes of armed antibody therapeutics against cancer

P2860

Q26771267-C712D759-8773-4E9F-93D5-1F961C1BE3FD Q33412734-FFD0531F-082A-4344-A31C-DC1D3A06B6FC Q35068030-C371986F-3568-48DF-9966-6D559D1F7290 Q35075470-D45F7728-587C-4088-9F51-DFC524C319A8 Q36411863-CAB8889C-DCD5-439D-89A1-04AF797F2399 Q37185752-3EC3C187-A377-4D39-A46C-5A072DB40271 Q38268464-0D5B57D4-EF0F-4368-BC39-83506ABC3938 Q38988662-C5A98A71-2931-4FEF-BD5E-8315618E8CC2 Q42031689-7347E873-B048-4ACA-BF46-578E9967117D Q42906644-7D4F792B-B806-4276-8DAE-099234838EED Q43708720-96094029-A358-428A-A8AD-330A2B7A39C2 Q45094027-2457B4CA-E5D2-4C7C-A533-9295CFD59D1A Q45225869-3F67C38D-1213-4BFE-86E8-E9462A8AEA5F Q45869295-662C991E-70BD-4C8D-8320-11CA0BAE96C1 Q47152190-B25D02D1-3AC3-444B-8848-4BC43203662D Q47329655-48AF0D73-14BD-4E73-8BE1-B5CCC6A00C83 Q50073502-B4760B2D-57B5-4C66-9223-1087CE0DEB18 Q51740406-040206B2-0BFD-4F4B-81C5-64645BE518E0 Q57911948-720E6CC3-5C90-4AB0-A2A6-DC02B5ED789D

P2860

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

http://www.wikidata.org/entity/Q33401165

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@ast

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@en

type

label

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@ast

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@en

prefLabel

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@ast

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@en

P1433

Q33401165-10BA3275-D55F-462E-99F9-707AE4715A86

P1476

Q33401165-80D1AB8D-D733-4AEC-9FC5-BB9E62670385

P2093

Q33401165-2084F7E3-B24D-4007-A777-056F47E91A93

Q33401165-2319E08C-F398-4703-9365-3488C10A5984

Q33401165-429A5D0F-2B14-477F-851A-0826E6D78E79

Q33401165-4423E486-D6E4-4D2F-B11A-4DE8A4D55183

Q33401165-559999FA-3330-4D57-B790-4F8DBD83711F

Q33401165-5D6A24B8-6968-4E8D-B7DA-E179ED4C6496

Q33401165-783D138C-F811-467D-A1D6-6333E404C0CB

Q33401165-8C94C098-EB82-4A22-898B-A4BA8A048F7B

Q33401165-9DE6FC73-EAB9-40F4-96CD-2DAC4532D6A2

P304

Q33401165-83AE4488-9E8E-4A2A-87E6-3A146F6B7207

P31

Q33401165-5333E873-1F30-41C6-83BE-D5234E9C8C53

P356

Q33401165-D3A5DFA1-7A5C-4866-8B0D-E44B52D1C00F

P407

Q33401165-D7683108-A009-4B4F-B548-54203149B0D6

P433

Q33401165-5E8E23A6-16DB-4E85-AD9C-ACDF86B94432

P478

Q33401165-B95AE8BD-AFF0-4BF6-A3A7-2EBFC434555C

P50

Q33401165-13FAA50E-1CF0-4584-962A-746F2D214CA2

Q33401165-1B7694C8-0BF3-4405-B401-F48DC72E5FFA

Q33401165-2564C979-F156-4BF3-A324-FF241F6527A1

P577

Q33401165-1221998F-DF70-45FC-999A-7E9466B1775A

P698

Q33401165-AB9B8FBE-E432-481C-9ED2-AF6628D8C50B

P356

JNUMED.111.101006

P1433

The Journal of Nuclear Medicine

P1476

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

@en

P2093

Chiara Grana

http://www.w3.org/2001/XMLSchema#string

Claudio Traino

http://www.w3.org/2001/XMLSchema#string

Emilio Bombardieri

http://www.w3.org/2001/XMLSchema#string

Enrico Orciuolo

http://www.w3.org/2001/XMLSchema#string

Giuliano Mariani

http://www.w3.org/2001/XMLSchema#string

Hans D Menssen

http://www.w3.org/2001/XMLSchema#string

Leonardo Giovannoni

http://www.w3.org/2001/XMLSchema#string

Mario Petrini

http://www.w3.org/2001/XMLSchema#string

Paola A Erba

http://www.w3.org/2001/XMLSchema#string

P304

922-927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.111.101006

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Martina Sollini

Giovanni Paganelli

P577

2012-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22577235

http://www.w3.org/2001/XMLSchema#string